Acadia Healthcare Company Inc (NASDAQ:ACHC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Thursday.
According to Zacks, “Acadia Healthcare severely suffers from steeply rising level of debt that results in growing interest expenses. The company’s worldwide operations lead to an immense exposure to volatile foreign exchange rate. Substantial integration risks associated with its frequent acquisitions also remain a major headwind. The Zacks Consensus Estimate for both 2017 and 2018 has revised downward in last sixty days. However, the company is well positioned for long term growth on the back of its inorganic strategies. The latest Priory acquisition has substantially enhanced its asset base as the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in diversifying the business risk. Year to date, the shares of Acadia Healthcare have gained 33% compared to 18% gain registered by the Zacks Hospitals industry.”
Other analysts have also issued research reports about the stock. Citigroup Inc started coverage on shares of Acadia Healthcare Company in a research note on Wednesday, January 4th. They issued a “buy” rating and a $43.00 price objective on the stock. Royal Bank of Canada reiterated a “buy” rating and issued a $56.00 price objective on shares of Acadia Healthcare Company in a research note on Tuesday, January 3rd. Jefferies Group LLC set a $55.00 price objective on shares of Acadia Healthcare Company and gave the stock a “buy” rating in a research note on Tuesday, December 20th. Cantor Fitzgerald reiterated a “buy” rating on shares of Acadia Healthcare Company in a research note on Thursday, December 15th. Finally, Mizuho reiterated a “buy” rating and issued a $52.00 price objective (up previously from $45.00) on shares of Acadia Healthcare Company in a research note on Monday, February 27th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $59.00.
Shares of Acadia Healthcare Company (NASDAQ:ACHC) traded up 0.63% during trading on Thursday, reaching $43.11. 583,235 shares of the company were exchanged. The company’s 50-day moving average is $42.90 and its 200 day moving average is $40.02. Acadia Healthcare Company has a 1-year low of $32.54 and a 1-year high of $65.00. The firm has a market capitalization of $3.77 billion, a PE ratio of 615.86 and a beta of 0.91.
Acadia Healthcare Company (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, February 23rd. The company reported $0.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.04. The firm had revenue of $702.89 million for the quarter, compared to analyst estimates of $708.41 million. Acadia Healthcare Company had a net margin of 0.22% and a return on equity of 8.91%. The business’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.59 earnings per share. Equities research analysts expect that Acadia Healthcare Company will post $2.46 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This news story was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2017/04/21/acadia-healthcare-company-inc-achc-downgraded-by-zacks-investment-research-to-sell-updated.html.
In other news, VP Randall P. Goldberg sold 914 shares of Acadia Healthcare Company stock in a transaction dated Wednesday, March 8th. The shares were sold at an average price of $43.55, for a total value of $39,804.70. Following the sale, the vice president now owns 7,376 shares in the company, valued at $321,224.80. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 17.20% of the stock is owned by company insiders.
Several hedge funds have recently made changes to their positions in ACHC. Seven Eight Capital LP acquired a new position in Acadia Healthcare Company during the fourth quarter valued at $152,000. Pacad Investment Ltd. acquired a new position in Acadia Healthcare Company during the fourth quarter valued at $166,000. Advisors Asset Management Inc. increased its position in Acadia Healthcare Company by 553.9% in the third quarter. Advisors Asset Management Inc. now owns 3,760 shares of the company’s stock valued at $186,000 after buying an additional 3,185 shares in the last quarter. Keybank National Association OH increased its position in Acadia Healthcare Company by 30.4% in the fourth quarter. Keybank National Association OH now owns 6,049 shares of the company’s stock valued at $200,000 after buying an additional 1,410 shares in the last quarter. Finally, Sciencast Management LP acquired a new position in Acadia Healthcare Company during the fourth quarter valued at $249,000.
About Acadia Healthcare Company
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Company Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc and related companies with MarketBeat.com's FREE daily email newsletter.